Macrophage Polarization in Leishmaniasis: Broadening Horizons
- PMID: 30429856
- PMCID: PMC6220043
- DOI: 10.3389/fimmu.2018.02529
Macrophage Polarization in Leishmaniasis: Broadening Horizons
Abstract
Leishmaniasis is a vector-borne neglected tropical disease that affects more than 700,000 people annually. Leishmania parasites cause the disease, and different species trigger a distinct immune response and clinical manifestations. Macrophages are the final host cells for the proliferation of Leishmania parasites, and these cells are the key to a controlled or exacerbated response that culminates in clinical manifestations. M1 and M2 are the two main macrophage phenotypes. M1 is a pro-inflammatory subtype with microbicidal properties, and M2, or alternatively activated, is an anti-inflammatory/regulatory subtype that is related to inflammation resolution and tissue repair. The present review elucidates the roles of M1 and M2 polarization in leishmaniasis and highlights the role of the salivary components of the vector and the action of the parasite in the macrophage plasticity.
Keywords: Leishmania; chemokine; classical macrophage; immunomodulation; non-classical macrophage; vector saliva.
Figures
Similar articles
-
New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis.Front Immunol. 2021 Jun 25;12:704429. doi: 10.3389/fimmu.2021.704429. eCollection 2021. Front Immunol. 2021. PMID: 34249011 Free PMC article. Review.
-
Macrophage Polarization in Chronic Inflammatory Diseases: Killers or Builders?J Immunol Res. 2018 Jan 14;2018:8917804. doi: 10.1155/2018/8917804. eCollection 2018. J Immunol Res. 2018. PMID: 29507865 Free PMC article. Review.
-
Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model.Immunobiology. 2018 Jun-Jul;223(6-7):493-500. doi: 10.1016/j.imbio.2017.12.003. Epub 2017 Dec 28. Immunobiology. 2018. PMID: 29317110
-
All-Trans Retinoic Acid Promotes an M1- to M2-Phenotype Shift and Inhibits Macrophage-Mediated Immunity to Leishmania major.Front Immunol. 2017 Nov 17;8:1560. doi: 10.3389/fimmu.2017.01560. eCollection 2017. Front Immunol. 2017. PMID: 29204144 Free PMC article.
-
Cathelicidin-WA polarizes E. coli K88-induced M1 macrophage to M2-like macrophage in RAW264.7 cells.Int Immunopharmacol. 2018 Jan;54:52-59. doi: 10.1016/j.intimp.2017.10.013. Epub 2017 Nov 2. Int Immunopharmacol. 2018. PMID: 29101873
Cited by
-
Mammalian Neuropeptides as Modulators of Microbial Infections: Their Dual Role in Defense versus Virulence and Pathogenesis.Int J Mol Sci. 2021 Apr 1;22(7):3658. doi: 10.3390/ijms22073658. Int J Mol Sci. 2021. PMID: 33915818 Free PMC article. Review.
-
Mechanobiology of immune cells: Messengers, receivers and followers in leishmaniasis aiding synthetic devices.Curr Res Immunol. 2022 Aug 23;3:186-198. doi: 10.1016/j.crimmu.2022.08.007. eCollection 2022. Curr Res Immunol. 2022. PMID: 36051499 Free PMC article. Review.
-
The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses.Virulence. 2022 Dec;13(1):903-935. doi: 10.1080/21505594.2022.2074130. Virulence. 2022. PMID: 35531875 Free PMC article. Review.
-
Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections.Front Immunol. 2022 Jan 26;13:780839. doi: 10.3389/fimmu.2022.780839. eCollection 2022. Front Immunol. 2022. PMID: 35154105 Free PMC article. Review.
-
Bidirectional cytokine-microRNA control: A novel immunoregulatory framework in leishmaniasis.PLoS Pathog. 2022 Aug 4;18(8):e1010696. doi: 10.1371/journal.ppat.1010696. eCollection 2022 Aug. PLoS Pathog. 2022. PMID: 35925884 Free PMC article. Review.
References
-
- World Health Organization Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014. Relev Epidemiol Hebd. (2016) 91:287–96. - PubMed
-
- World Health Organization (2018). Leishmaniasis. Available online at: http://www.who.int/news-room/fact-sheets/detail/leishmaniasis
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical